Human Hepatitis B Immunoglobulin Market

Human Hepatitis B Immunoglobulin Market contains market size and forecasts of Human Hepatitis B Immunoglobulin in global, including the following market information:

Global Human Hepatitis B Immunoglobulin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Hepatitis B Immunoglobulin Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Human Hepatitis B Immunoglobulin companies in 2021 (%)

The global Human Hepatitis B Immunoglobulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Hepatitis B Immunoglobulin include Baxter, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, China Biologic and Tiantan Biologic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Hepatitis B Immunoglobulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Hepatitis B Immunoglobulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Human Hepatitis B Immunoglobulin Market Segment Percentages, by Type, 2021 (%)

• 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
• 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
• 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

Global Human Hepatitis B Immunoglobulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Human Hepatitis B Immunoglobulin Market Segment Percentages, by Application, 2021 (%)

• Hepatitis B Carrier
• Hepatitis B Close Contacts

Global Human Hepatitis B Immunoglobulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Human Hepatitis B Immunoglobulin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Human Hepatitis B Immunoglobulin revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Human Hepatitis B Immunoglobulin revenues share in global market, 2021 (%)
• Key companies Human Hepatitis B Immunoglobulin sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Human Hepatitis B Immunoglobulin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Baxter
• CSL
• Bayer
• Grifols
• Octapharma
• Shanghai RAAS
• Hualan Biological
• China Biologic
• Tiantan Biologic
• Shuanglin Bio-pharmacy
• Sichuan Yuanda Shuyang
• Boya Bio-pharmaceutical
• Shanghai Institute of Biological